Navigation Links
Sihuan Pharmaceutical Announces 2013 Interim Results
Date:8/26/2013

s are expected to be launched starting from 2015.

In view of strong future growth, the Company will continue to enhance its nationwide distribution network and sales and marketing capabilities. Meanwhile, the Company will continue to exploring opportunities and enhancing its R&D capability by continuous investment in order to sustain healthy and sustainable growth.

Dr. Che concluded, "Despite increasingly rigid demand in the pharmaceutical industry, changes in policies and intense market competition continue to pose challenges to the industry's development. As an innovative pharmaceutical company which focuses on exclusive and proprietary products, Sihuan Pharmaceutical has sharpened its advantage in resources amidst the challenging market environment. Backed by its outstanding capabilities in sales and marketing, R&D and resource integration, Sihuan Pharmaceutical is poised to capitalize on the trend of industry consolidation and to achieve sustainable development going forward. I am highly confident in Sihuan's 2013 full year operating results and the Company's future development, and firmly believe that it will welcome a new era of development by entering into a steady growth trajectory. We are taking concrete steps towards our goal of becoming the most competitive Chinese pharmaceutical company." 

About Sihuan Pharmaceutical Holdings Group Ltd.Founded in 2001, Sihuan Pharmaceutical Holdings Group Ltd. is a leading Chinese pharmaceutical corporation and the largest cardio-cerebral vascular drug franchise in China's prescription drug market by market share. The Company also became the third largest pharmaceutical company in terms of hospital purchase in the Chinese prescription drug market in the first half of 2013. The success of the Group can be attributed to its differentiated and proven sales and marketing model, extensive nationwide distribution network, young and diversified product portfolio, and
'/>"/>

SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
2. Sihuan Pharmaceutical Announces 2012 Annual Results
3. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
4. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
5. Sihuans First-to-market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production
6. Sihuan Pharmaceutical Announces 2012 Interim Results
7. Sihuans First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
8. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
9. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
10. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
11. Par Pharmaceutical Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)...  Novartis Pharmaceuticals Corporation (NPC) has been named the top ... on the annual DiversityInc Top 50 Companies for Diversity listing. ... for Diversity on April 23 at an awards ceremony in ... second on the DiversityInc Top 10 Companies for Recruitment list ... Groups list. David Epstein , Division ...
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/24/2015)... Spain , April 24, 2015  Elekta has ... Monaco® treatment planning system , enabling European clinics ... supports major treatment techniques including advanced 3D planning, IMRT, ... system. Monaco ... as well improved workflow efficiency. Advancements in 3D planning ...
Breaking Medicine Technology:Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Lannett Expands Revolving Credit Facility To $120 Million 2Elekta CE marks for Monaco v5.10 treatment planning system 2
... VALLEY FORGE, Pa., June 13, 2011 Saint-Gobain ... adding a variety of ergonomic features that improve ... and solution storage applications. These improvements are based ... laboratory and pharmaceutical environments. Manufactured from ...
... Today Divine Skin Inc. (DSKX), a developer of ... analgesic intended to compete over the counter with the ... to begin shipping upon final authorization by the Drug ... on underserved and niche categories, of course our pain ...
Cached Medicine Technology:New Bio-Simplex™ Polypropylene Carboys Feature Ergonomic Design, Versatile Closure Options 2New Bio-Simplex™ Polypropylene Carboys Feature Ergonomic Design, Versatile Closure Options 3Divine Skin Announces New Pain Reliever to Compete With Tylenol, Advil, Aspirin 2Divine Skin Announces New Pain Reliever to Compete With Tylenol, Advil, Aspirin 3
(Date:4/26/2015)... Italian public health researchers have released new data ... and other asbestos-related industries. Surviving Mesothelioma has just posted ... to read it now. , University researchers ... Medicine analyzed more than 15,000 cases of mesothelioma between ... asbestos cancer was most common. , “Asbestos cement ...
(Date:4/26/2015)... From March 18th, 2015 toward the ... Master™ Dahryn Trivedi, spent a month traveling in India ... institutions in the efforts of creating highly advanced, effective ... for human health care. , During their journey, ... institutions. All lab facilities are approved by the U.S. ...
(Date:4/26/2015)... In an article published last month in ... biomechanics occurring during the use of handheld electronic devices such ... that use of a tablet increases mechanical demand on neck ... more than when the neck is in a neutral position. ... pointing out the potential hazards of overuse of mobile technology ...
(Date:4/25/2015)... The National League for Nursing's ... endeavor to prepare nurses to provide high quality, culturally ... according to a new report by the John A. ... , The project began in 2007 as a ... direction of Elaine Tagliareni, EdD, RN, CNE, FAAN, professor ...
(Date:4/25/2015)... The Hon. Ellen Tauscher, Independent Chair ... following statement following the deadly earthquake in Nepal: , ... in the deaths of more than 1,000 people. ... Nepal, Bangladesh, India and other parts of South Asia. ... the people of Nepal and the families of the ...
Breaking Medicine News(10 mins):Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3
... Feb. 7 PartnerRe Ltd.,(NYSE: PRE ) announced ... the period December 1, 2007 - February 29, 2008 ... Cumulative Redeemable Preferred Shares, and,$0.40625 per share on the ... will be payable on March 3, 2008, to,shareholders of ...
... NHS Choices ( http://www.nhs.uk ), the,online ,front door, ... information,resource, Health A-Z, aimed to help people find ... Based on NHS accredited information, the A-Z directory,( ... on a topic in seconds, providing them with ...
... that run on both conventional gasoline and stored ... gap until more sustainable technology is developed, according ... publication International Journal of Automotive Technology and Management, ... even slow development of more sustainable fuel-cell powered ...
... release was issued,today jointly by Schiffrin Barroway Topaz & ... DISTRICT COURT DISTRICT OF MARYLAND (NORTHERN DIVISION), ... LITIGATION Civil Action No. MJG 05-1224, SUMMARY ... ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED ...
... Comes With Software that Provides Hands-on Learning, ... a patient,s,medical records is essential to quality medical ... and death of a patient. Electronic Health,Record (EHR) ... make patient history readily available in those critical ...
... Environmental Health Groups Call for Immediate Moratorium on Bisphenol,A ... CHURCH, Va., Jan. 7 Dozens of state,and national ... for an immediate moratorium on the use of bisphenol ... containers, based on the results of a,new study that ...
Cached Medicine News:Health News:The trouble with hybrids 2Health News:Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation 2Health News:McGraw-Hill Higher Education Publishes Text on Innovative Electronic Health Records System 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 4
... Vitamin D kit is an enzymeimmunoassay for ... hydroxylated metabolites in serum or plasma. Calibrators, ... labelled 25-OH D. The diluted samples are ... with a highly specific sheep 25-OH D ...
... for the control of glucose metabolism. It ... of Langerhans as the precursor, proinsulin, which is ... are secreted in equimolar amounts into the portal ... of two polypeptide chains, the A-chain and B-chain ...
... is an integral part of the enzymatic ... II as well as the degradation of ... ACE is primarily located in endothelial cells. ... parameter for sarcoidosis and myocardial infarction but ...
... Retinol binding Proetin (RBP) is small (21kD) ... complex with pre-albumin in blood but loses ... been deliverd to the target cells. The ... the glomerulus and catabolized in the,renal tubules ...
Medicine Products: